Patients Satisfied With Shared Appointments Before Mohs Sx

This article originally appeared here.
Share this content:
Patients Satisfied With Shared Appointments Before Mohs Sx
Patients Satisfied With Shared Appointments Before Mohs Sx

(HealthDay News) -- Patient satisfaction is high for shared medical appointments (SMAs) for preoperative consultation regarding Mohs micrographic surgery, according to a study published in the February issue of the Journal of the American Academy of Dermatology.

Thomas J. Knackstedt, M.D., and Faramarz H. Samie, M.D., Ph.D., from the Dartmouth-Hitchcock Medical Center in Lebanon, N.H., conducted a pilot study to examine patient satisfaction with SMAs for preoperative consultation for Mohs micrographic surgery. They assessed patient satisfaction over a six-month period using a 13-question survey.

Among 149 patients who were seen in SMAs, the survey response rate was 65.8 percent. The researchers found that the mean value on Likert scale questions was 4.29 ± 0.09 (on a 1 to 5 scale, where 5 is best). The SMA model was found to be useful (84.7 percent), and most participants reported that they would attend an SMA in the future (80.6 percent).

"SMA can be successfully used for the Mohs preoperative consultation visit with high patient satisfaction," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Global Prevalence of Insufficient Activity 27.5 Percent

Global Prevalence of Insufficient Activity 27.5 Percent

Levels of insufficient physical activity stable between 2001, 2016; increase seen in high-income countries

HTN Tx Intensification Common Upon Discharge in U.S. Vets

HTN Tx Intensification Common Upon Discharge in U.S. ...

Fourteen percent of older adults admitted to hospital for non-cardiac conditions had intensification of tx

Quarterly Canakinumab Reduces Risk for Gout Attacks

Quarterly Canakinumab Reduces Risk for Gout Attacks

Doesn't affect serum uric acid levels over time, but targets interleukin-1β

is free, fast, and customized just for you!




Already a member?

Sign In Now »